Diabetic Eye Awareness

According to review, patients with mild diabetic retinopathy at baseline fare better.

A University of Houston study found that minorities have fewer eye exams, higher instances of disease.

Alimera Sciences, Inc. announces statistically significant improvements in best corrected visual acuity, central subfield thickness and treatment burden for patients with diabetic macular edema.

Leading the charge for a multifactorial approach to combat diabetes, Kristen Nwanyanwu, MD, MBA, MHS, and her team have embraced the need for a multi-pronged program to address health disparities in diabetic retinopathy.

The difference in visual acuities based on CST fluctuations in these patients with diabetic macular edema remained significant.

Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.

Novartis has revealed the first interpretable results from year two (week 100) of the Phase III KESTREL study.

SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.

Speaking at the American Society of Retina Specialists 2021 annual meeting in San Antonio, Rishi P. Singh, MD, provided results of the VISTA and VIVID studies, and he pointed out that the findings could help physicians set expectations of DME therapy.

A new study reveals that children of mothers with diabetes during pregnancy have an increased risk of eye problems.

Investigators corroborate the hypothesis that retinal ganglion cells with dendrites stratified in the off sublaminae could be damaged.

In endophthalmitis, the systemic anti-infective treatment specific to the infectious agent should always be used.

Study explores correlations between functional and structural tests

The number of patients with retinal diseases is steadily increasing in the United States, according to a retrospective study presented during ARVO 2020.

Rates of anxiety and depression increased but were not necessarily tied to disease severity

A retrospective study found that in both patients with type 2 diabetes and non-diabetics, average central macular thickness was lower in Asians than Caucasians. Why is this significant for clinicians?

Intravitreal liposome-encapsulated bromfenac is under study as a treatment for refractory DME. Results of a pilot study were detailed at the virtual 2020 ASRS annual meeting.